CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-04 | Griffin Deborah A Chief Accounting Officer | Option exercise | +4,807 | 4,807 | ||
| 2020-03-04 | Griffin Deborah A Chief Accounting Officer | Sale | −4,807 | $11.23 | $54K | 0 |
| 2020-03-04 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −4,807 | 14,424 | ||
| 2020-03-03 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +1,166 | 14,622.49 | ||
| 2020-03-03 | O'Grady Brendan P. EVP, North America Commercial | Sale | −463 | $11.37 | $5K | 14,159.49 |
| 2020-03-03 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −1,166 | 1,166 | ||
| 2020-03-03 | Nazzi Gianfranco EVP, International Markets | Option exercise | +1,399 | 19,863.36 | ||
| 2020-03-03 | Nazzi Gianfranco EVP, International Markets | Sale | −548 | $11.77 | $6K | 19,315.36 |
| 2020-03-03 | Nazzi Gianfranco EVP, International Markets | Option exercise · Restricted Share Units | −1,399 | 1,400 | ||
| 2020-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,399 | 19,459.7 | ||
| 2020-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,399 | 1,400 | ||
| 2020-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise | +2,098 | 10,710 | ||
| 2020-03-03 | Daniell Richard Exec. VP, European Commercial | Sale | −991 | $11.77 | $12K | 9,719 |
| 2020-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −2,098 | 2,101 | ||
| 2020-03-03 | Griffin Deborah A Chief Accounting Officer | Option exercise | +1,166 | 1,166 | ||
| 2020-03-03 | Griffin Deborah A Chief Accounting Officer | Sale | −1,166 | $11.37 | $13K | 0 |
| 2020-03-03 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −1,166 | 1,166 | ||
| 2020-03-02 | Griffin Deborah A Chief Accounting Officer | Option exercise | +2,941 | 2,941 | ||
| 2020-03-02 | Griffin Deborah A Chief Accounting Officer | Sale | −2,941 | $11.60 | $34K | 0 |
| 2020-03-02 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −2,941 | 5,882 |
Page 57 of 76 · 1,517 trades